Inventor · disambiguated record
Andrew Buchanan
Also filed as: BUCHANAN ANDREW · BUCHANAN ANDREW G · BUCHANAN ANDREW GRIER
19 granted patents·7 pending applications·51 citations·filing 2005–2024
92Inventor score
Top patents by PatentIndex Score
26 records- 0189US10954308B2Antibodies to ticagrelor and methods of useMEDIMMUNE LTD·Filed 2018·Granted Mar 23, 2021·4 cites·30 claims
- 0286US11773186B2Antibodies to ticagrelor and methods of useMEDIMMUNE LTD·Filed 2021·Granted Oct 3, 2023·1 cites·15 claims
- 0386US9982061B2Antibodies to ticagrelor and methods of useMEDIMMUNE LTD·Filed 2015·Granted May 29, 2018·6 cites·4 claims
- 0485US12391768B2Antibodies to ticagrelor and methods of useMEDIMMUNE LTD·Filed 2023·Granted Aug 19, 2025·0 cites·17 claims
- 0585US10487154B2Antibodies to ticagrelor and methods of useMEDIMMUNE LTD·Filed 2018·Granted Nov 26, 2019·4 cites·17 claims
- 0683US8507656B2Stabilized angiopoietin-2 antibodies and uses thereofBEDIAN VAHE·Filed 2009·Granted Aug 13, 2013·6 cites·15 claims
- 0779US8088736B2CTLA-4 protein variantsFRANKS RUTH·Filed 2007·Granted Jan 3, 2012·9 cites·19 claims
- 0875US11078284B2Antibodies specific for LOX1 and use in treatment of cardiovascular disordersMEDIMMUNE LTD·Filed 2018·Granted Aug 3, 2021·1 cites·19 claims
- 0975US10077319B2Anti-PCSK9-GLP-1 fusions and methods for useMEDIMMUNE LLC·Filed 2015·Granted Sep 18, 2018·3 cites·20 claims
- 1072US8935892B2Engineered wood construction system for high performance structuresBUCHANAN ANDREW·Filed 2012·Granted Jan 20, 2015·11 cites·33 claims
- 1172US2024360226A1Antibody molecules and conjugatesASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1271US12065496B2Antibody molecules and conjugatesASTRAZENECA AB·Filed 2022·Granted Aug 20, 2024·0 cites·27 claims
- 1368US10077305B2Antibodies against PD-1 and uses thereofMEDIMMUNE LTD·Filed 2014·Granted Sep 18, 2018·1 cites·11 claims
- 1467US10117889B2Antibodies specific for LOX1 and use in treatment of cardiovascular disordersMEDIMMUNE LTD·Filed 2015·Granted Nov 6, 2018·1 cites·20 claims
- 1566US9315571B2Specific binding members for NGFFRANKS RUTH·Filed 2006·Granted Apr 19, 2016·1 cites·9 claims
- 1664US2021347900A1Antibodies specific for lox1 and use in treatment of cardiovascular disordersMEDIMMUNE LTD·Filed 2021·Application pending·0 cites
- 1758US10329345B2Stabilized angiopoietin-2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2016·Granted Jun 25, 2019·0 cites·15 claims
- 1854US2025121104A1Egfr-cmet-targeted compounds and uses thereofFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1953US2013280251A1Stabilized Angiopoietin-2 Antibodies And Uses ThereofBEDIAN VAHE·Filed 2013·Application pending·0 cites
- 2053US2010186316A1Engineered Wood Construction System for High Performance StructuresBUCHANAN ANDREW·Filed 2007·Application pending·0 cites
- 2147US9701746B2Methods of treating neuropathic pain with specific binding members for NGFMEDIMMUNE LTD·Filed 2016·Granted Jul 11, 2017·0 cites·6 claims
- 2242USD988335SDisplay screen or portion thereof with graphical user interfaceVISA INT SERVICE ASS·Filed 2019·Granted Jun 6, 2023·3 cites·1 claims
- 2342US8288123B2Methods and means relating to protein variantsBUCHANAN ANDREW·Filed 2006·Granted Oct 16, 2012·0 cites·41 claims
- 2441US2019092877A1Anti-pcsk9-glp-1 fusions and methods for useMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 2540USD1101768SCombined electronic device and display screen or portion thereof with graphical user interfaceVISA INT SERVICE ASS·Filed 2023·Granted Nov 11, 2025·0 cites·1 claims
- 2639US2008194475A1Erythropoietin Protein VariantsBUCHANAN ANDREW·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Buchanan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →